Revere Pharmaceuticals
PrivateLast Round
M&A
Feb 22, 2021
Total Funding Raised
$3.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Revere Pharmaceuticals is a biotechnology company developing small molecule therapeutics targeting Rho GTPase proteins for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revere Pharmaceuticals Comparables
Compare Revere Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MBQ Pharma | 87% | |
| SHY Therapeutics | 73% | |
| Revolution Medicines | 67% |
Revere Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Feb 22, 2021 | ||||
| Seed | Jun 22, 2020 |
Revere Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XLerateHealth | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 49% MoM, reaching 1.4K.
- Feb 2, 2026
Monthly visitors grew 686% MoM, reaching 904.
Revere Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revere Pharmaceuticals's valuation, stock price, and market status.
Is Revere Pharmaceuticals a public or private company?
Revere Pharmaceuticals is a private company.
What is the current stock price of Revere Pharmaceuticals?
Revere Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Revere Pharmaceuticals worth (valuation)?
Valuation information for Revere Pharmaceuticals is not publicly available.
Can I buy Revere Pharmaceuticals stock?
Revere Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revere Pharmaceuticals's last funding round?
Revere Pharmaceuticals's most recent funding round was M&A on February 22, 2021.
Who are the main investors in Revere Pharmaceuticals?
Key investors in Revere Pharmaceuticals include XLerateHealth.
Will Revere Pharmaceuticals IPO soon?
No public IPO plans have been announced for Revere Pharmaceuticals.
How can I track Revere Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revere Pharmaceuticals's secondary market activity and sign up for updates.